We should be done in such a way that patients with stage IV non-small cell lung cancer who would benefit from surgery are not overlooked

J Thorac Dis. 2018 Sep;10(Suppl 26):S3257-S3259. doi: 10.21037/jtd.2018.08.63.

Authors

Yasuhiro Chikaishi¹, Ayako Hirai¹, Naoko Imanishi¹, Yoshinobu Ichiki¹, Fumihiro Tanaka¹

Affiliation

¹ Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

No abstract available

Publication types

Editorial
Comment